Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil

• Published in: International journal of molecular sciences Vol. 22; no. 10; p. 5406
• Main Authors: Han, Jung Ho, Kim, MinJeong, Kim, Hyeon Jin, Jang, Se Bok, Bae, Sung-Jin, Lee, In-Kyu, Ryu, Dongryeol, Ha, Ki-Tae
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 20.05.2021; MDPI
• Subjects: 5-Fluorouracil; Apoptosis; Binding sites; Catechin; Cell growth; Chemoresistance; chemoresistant; Chemotherapy; Colorectal cancer; Cytotoxicity; Dehydrogenases; Drug dosages; Drug resistance; Epigallocatechin gallate; Gastric cancer; Glycolysis; Inflammation; Kinases; L-Lactate dehydrogenase; Lactate dehydrogenase; Lactic acid; Natural products; Oxidative phosphorylation; Pancreatic cancer; Phosphorylation; Polyphenols; Protein expression; Proteins; Tumor cell lines
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22105406

Resistance to anticancer therapeutics occurs in virtually every type of cancer and becomes a major difficulty in cancer treatment. Although 5-fluorouracil (5FU) is the first-line choice of anticancer therapy for gastric cancer, its effectiveness is limited owing to drug resistance. Recently, altered cancer metabolism, including the Warburg effect, a preference for glycolysis rather than oxidative phosphorylation for energy production, has been accepted as a pivotal mechanism regulating resistance to chemotherapy. Thus, we investigated the detailed mechanism and possible usefulness of antiglycolytic agents in ameliorating 5FU resistance using established gastric cancer cell lines, SNU620 and SNU620/5FU. SNU620/5FU, a gastric cancer cell harboring resistance to 5FU, showed much higher lactate production and expression of glycolysis-related enzymes, such as lactate dehydrogenase A (LDHA), than those of the parent SNU620 cells. To limit glycolysis, we examined catechin and its derivatives, which are known anti-inflammatory and anticancer natural products because epigallocatechin gallate has been previously reported as a suppressor of LDHA expression. Catechin, the simplest compound among them, had the highest inhibitory effect on lactate production and LDHA activity. In addition, the combination of 5FU and catechin showed additional cytotoxicity and induced reactive oxygen species (ROS)-mediated apoptosis in SNU620/5FU cells. Thus, based on these results, we suggest catechin as a candidate for the development of a novel adjuvant drug that reduces chemoresistance to 5FU by restricting LDHA.